Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip G Janicak

Showing results (1-10 of 46) with videos related to

Pageof 5
Sort By:
CNS Spectrums|June 11, 2008
An interview with Philip G. Janicak, MD: Neuromodulation by Norman Sussman, MDPhilip G Janicak
Essential Psychopharmacology|September 23, 2006
The CATIE study and its implications for antipsychotic drug usePhilip G Janicak
Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists|December 25, 2010
Transcranial magnetic stimulation for major depressive disorder: introductionPhilip G Janicak
Journal of Psychosocial Nursing and Mental Health Services|August 8, 2007
Vagus nerve stimulation for severe depressionJeffrey Rado, Philip G Janicak
Clinical Interventions in Aging|September 21, 2010
Aripiprazole for late-life schizophreniaJeffrey Rado, Philip G Janicak
Drugs & Aging|September 29, 2012
Pharmacological and clinical profile of recently approved second-generation antipsychotics: implications for treatment of schizophrenia in older patientsJeffrey Rado, Philip G Janicak
Expert Opinion on Pharmacotherapy|July 1, 2010
Iloperidone for schizophreniaJeffrey Rado, Philip G Janicak
Neuropsychiatric Disease and Treatment|March 7, 2014
Long-term efficacy and safety of iloperidone: an updateJeffrey T Rado, Philip G Janicak
Expert Opinion on Pharmacotherapy|May 5, 2012
Quetiapine for the treatment of acute bipolar mania, mixed episodes and maintenance therapyPhilip G Janicak, Jeffrey T Rado
Neuropsychiatric Disease and Treatment|July 15, 2015
Transcranial magnetic stimulation for the treatment of major depressionPhilip G Janicak, Mehmet E Dokucu
Pageof 5

Showing results (1-10 of 46) with videos related to

Sort By:
Pageof 5
CNS Spectrums|June 11, 2008
An interview with Philip G. Janicak, MD: Neuromodulation by Norman Sussman, MDPhilip G Janicak
Essential Psychopharmacology|September 23, 2006
The CATIE study and its implications for antipsychotic drug usePhilip G Janicak
Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists|December 25, 2010
Transcranial magnetic stimulation for major depressive disorder: introductionPhilip G Janicak
Journal of Psychosocial Nursing and Mental Health Services|August 8, 2007
Vagus nerve stimulation for severe depressionJeffrey Rado, Philip G Janicak
Clinical Interventions in Aging|September 21, 2010
Aripiprazole for late-life schizophreniaJeffrey Rado, Philip G Janicak
Drugs & Aging|September 29, 2012
Pharmacological and clinical profile of recently approved second-generation antipsychotics: implications for treatment of schizophrenia in older patientsJeffrey Rado, Philip G Janicak
Expert Opinion on Pharmacotherapy|July 1, 2010
Iloperidone for schizophreniaJeffrey Rado, Philip G Janicak
Neuropsychiatric Disease and Treatment|March 7, 2014
Long-term efficacy and safety of iloperidone: an updateJeffrey T Rado, Philip G Janicak
Expert Opinion on Pharmacotherapy|May 5, 2012
Quetiapine for the treatment of acute bipolar mania, mixed episodes and maintenance therapyPhilip G Janicak, Jeffrey T Rado
Neuropsychiatric Disease and Treatment|July 15, 2015
Transcranial magnetic stimulation for the treatment of major depressionPhilip G Janicak, Mehmet E Dokucu
Pageof 5